ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
Compounder50
|
758 |
342K |
7 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
758
|
342K
|
7
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
Compounder50
|
758 |
342K |
4 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
758
|
342K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
4 billion market cap breached
|
|
Compounder50
|
15 |
7.2K |
9 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
15
|
7.2K
|
9
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
Compounder50
|
758 |
342K |
11 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
758
|
342K
|
11
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
Compounder50
|
758 |
342K |
7 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
758
|
342K
|
7
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Q1 2024 Revenue and Business Update
|
|
Compounder50
|
135 |
49K |
13 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
135
|
49K
|
13
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
Compounder50
|
758 |
342K |
7 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
758
|
342K
|
7
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
Compounder50
|
758 |
342K |
6 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
758
|
342K
|
6
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
Compounder50
|
1.5K |
563K |
11 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
1.5K
|
563K
|
11
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
Compounder50
|
758 |
342K |
8 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
758
|
342K
|
8
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
Compounder50
|
1.5K |
563K |
10 |
30/12/23 |
30/12/23 |
ASX - By Stock
|
1.5K
|
563K
|
10
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
Compounder50
|
380 |
113K |
16 |
26/09/23 |
26/09/23 |
ASX - By Stock
|
380
|
113K
|
16
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Presentation to Accompany AI Development Program Update
|
|
Compounder50
|
62 |
28K |
6 |
09/09/23 |
09/09/23 |
ASX - By Stock
|
62
|
28K
|
6
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
Compounder50
|
380 |
113K |
11 |
24/08/23 |
24/08/23 |
ASX - By Stock
|
380
|
113K
|
11
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
Compounder50
|
380 |
113K |
6 |
11/08/23 |
11/08/23 |
ASX - By Stock
|
380
|
113K
|
6
|
|
ASX - By Stock
|
TLX |
Re:
A collaboration with Starpharna
|
|
Compounder50
|
15 |
6.7K |
6 |
31/07/23 |
31/07/23 |
ASX - By Stock
|
15
|
6.7K
|
6
|
|
ASX - By Stock
|
TLX |
Re:
A collaboration with Starpharna
|
|
Compounder50
|
15 |
6.7K |
5 |
26/07/23 |
26/07/23 |
ASX - By Stock
|
15
|
6.7K
|
5
|
|
ASX - By Stock
|
TLX |
Re:
12 month price targets
|
|
Compounder50
|
29 |
12K |
6 |
24/07/23 |
24/07/23 |
ASX - By Stock
|
29
|
12K
|
6
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
Compounder50
|
1.5K |
563K |
9 |
20/07/23 |
20/07/23 |
ASX - By Stock
|
1.5K
|
563K
|
9
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
Compounder50
|
1.5K |
563K |
4 |
20/07/23 |
20/07/23 |
ASX - By Stock
|
1.5K
|
563K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Notification of upcoming quarterly results and investor call
|
|
Compounder50
|
69 |
23K |
7 |
13/07/23 |
13/07/23 |
ASX - By Stock
|
69
|
23K
|
7
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
Compounder50
|
1.5K |
563K |
6 |
03/07/23 |
03/07/23 |
ASX - By Stock
|
1.5K
|
563K
|
6
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Phase II study for indication expansion of TLX250-CDx doses
|
|
Compounder50
|
17 |
7.0K |
12 |
19/06/23 |
19/06/23 |
ASX - By Stock
|
17
|
7.0K
|
12
|
|
ASX - By Stock
|
RAD |
Re:
News: RAD Radiopharm Theranostics Says U.S. FDA Granted Orphan Drug Designation To GA68-TRIVEHEXIN
|
|
Compounder50
|
73 |
23K |
0 |
07/06/23 |
07/06/23 |
ASX - By Stock
|
73
|
23K
|
0
|
|
ASX - By Stock
|
RAD |
Re:
News: RAD Radiopharm Theranostics Says U.S. FDA Granted Orphan Drug Designation To GA68-TRIVEHEXIN
|
|
Compounder50
|
73 |
23K |
5 |
04/06/23 |
04/06/23 |
ASX - By Stock
|
73
|
23K
|
5
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
Compounder50
|
1.5K |
563K |
10 |
04/06/23 |
04/06/23 |
ASX - By Stock
|
1.5K
|
563K
|
10
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
Compounder50
|
1.5K |
563K |
3 |
31/05/23 |
31/05/23 |
ASX - By Stock
|
1.5K
|
563K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
New paper on expanded indication for PSMA PET
|
|
Compounder50
|
6 |
3.7K |
4 |
29/05/23 |
29/05/23 |
ASX - By Stock
|
6
|
3.7K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
Compounder50
|
1.5K |
563K |
10 |
26/05/23 |
26/05/23 |
ASX - By Stock
|
1.5K
|
563K
|
10
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
Compounder50
|
758 |
342K |
5 |
25/05/23 |
25/05/23 |
ASX - By Stock
|
758
|
342K
|
5
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
Compounder50
|
758 |
342K |
10 |
25/05/23 |
25/05/23 |
ASX - By Stock
|
758
|
342K
|
10
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
Compounder50
|
758 |
342K |
5 |
24/05/23 |
24/05/23 |
ASX - By Stock
|
758
|
342K
|
5
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Annual General Meeting - Presentation
|
|
Compounder50
|
17 |
7.2K |
10 |
24/05/23 |
24/05/23 |
ASX - By Stock
|
17
|
7.2K
|
10
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
Compounder50
|
1.5K |
563K |
13 |
22/05/23 |
22/05/23 |
ASX - By Stock
|
1.5K
|
563K
|
13
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Telix on Track to Deliver $400 Million-Plus Sales, Aims 1 Billion: CEO (Alan Kohler Interview)
|
|
Compounder50
|
15 |
7.7K |
12 |
22/05/23 |
22/05/23 |
ASX - By Stock
|
15
|
7.7K
|
12
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
Compounder50
|
1.5K |
563K |
6 |
17/05/23 |
17/05/23 |
ASX - By Stock
|
1.5K
|
563K
|
6
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
Compounder50
|
1.5K |
563K |
8 |
15/05/23 |
15/05/23 |
ASX - By Stock
|
1.5K
|
563K
|
8
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
Compounder50
|
1.5K |
563K |
12 |
11/05/23 |
11/05/23 |
ASX - By Stock
|
1.5K
|
563K
|
12
|
|
ASX - By Stock
|
RAD |
Re:
News: RAD Radiopharm Theranostics Says U.S. FDA Granted Orphan Drug Designation To GA68-TRIVEHEXIN
|
|
Compounder50
|
73 |
23K |
2 |
10/05/23 |
10/05/23 |
ASX - By Stock
|
73
|
23K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Those shorters are suffering
|
|
Compounder50
|
38 |
12K |
5 |
06/05/23 |
06/05/23 |
ASX - By Stock
|
38
|
12K
|
5
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Illuccix Granted Use Authorisation in Brazil
|
|
Compounder50
|
44 |
17K |
4 |
03/05/23 |
03/05/23 |
ASX - By Stock
|
44
|
17K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Illuccix Granted Use Authorisation in Brazil
|
|
Compounder50
|
44 |
17K |
6 |
03/05/23 |
03/05/23 |
ASX - By Stock
|
44
|
17K
|
6
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
Compounder50
|
1.5K |
563K |
10 |
03/05/23 |
03/05/23 |
ASX - By Stock
|
1.5K
|
563K
|
10
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
Compounder50
|
1.5K |
563K |
12 |
02/05/23 |
02/05/23 |
ASX - By Stock
|
1.5K
|
563K
|
12
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
Compounder50
|
1.5K |
563K |
9 |
02/05/23 |
02/05/23 |
ASX - By Stock
|
1.5K
|
563K
|
9
|
|
ASX - By Stock
|
TLX |
Re:
Ann: ZIRCON Data Presented at AUA Confirms Efficacy in 2cm Masses
|
|
Compounder50
|
10 |
4.2K |
5 |
01/05/23 |
01/05/23 |
ASX - By Stock
|
10
|
4.2K
|
5
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
Compounder50
|
1.5K |
563K |
4 |
01/05/23 |
01/05/23 |
ASX - By Stock
|
1.5K
|
563K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
Compounder50
|
1.5K |
563K |
2 |
27/04/23 |
27/04/23 |
ASX - By Stock
|
1.5K
|
563K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Presentation to Accompany AI Development Program Update
|
|
Compounder50
|
62 |
28K |
9 |
27/04/23 |
27/04/23 |
ASX - By Stock
|
62
|
28K
|
9
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
Compounder50
|
758 |
342K |
1 |
26/04/23 |
26/04/23 |
ASX - By Stock
|
758
|
342K
|
1
|
|